Deutsche Biotech Innovativ Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
1
- Stock Symbol
-
DBI
- Investments
-
4
- Share Price
-
$1.24
- (As of Monday Closing)
Deutsche Biotech Innovativ General Information
Description
Deutsche Biotech Innovativ AG operates as a biotechnology company in Germany. The group invests in biotechnology companies that pursue a research and development approach and develop drug candidates with a high degree of selling proposition.
Contact Information
Website
www.dbi-ag.deCorporate Office
- Neuendorfstrasse 15a
- 16761 Hennigsdorf
- Germany
Corporate Office
- Neuendorfstrasse 15a
- 16761 Hennigsdorf
- Germany
Deutsche Biotech Innovativ Stock Performance
As of 30-Sep-2024, Deutsche Biotech Innovativ’s stock price is $1.24. Its current market cap is $1.48M with 947K shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.24 | $1.22 | $1.17 - $19.52 | $1.48M | 947K | 423.33 | -$1.26 |
Deutsche Biotech Innovativ Financials Summary
As of 31-Dec-2025, Deutsche Biotech Innovativ has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,059 | 8,202 | ||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | 67 | 67 | (975) | (53) |
| Net Income | (42) | (42) | (1,075) | (1,181) |
| Total Assets | 2,012 | 2,012 | 1,788 | 1,774 |
| Total Debt | 0 | 0 | 0 | 0 |
Deutsche Biotech Innovativ Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Deutsche Biotech Innovativ Patents
Deutsche Biotech Innovativ Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10793626-B2 | Adrenomedullin binder for use in therapy of cancer | Active | 20-Dec-2013 | ||
| US-20160319007-A1 | Adrenomedullin binder for use in therapy of cancer | Active | 20-Dec-2013 |
Deutsche Biotech Innovativ Signals
Deutsche Biotech Innovativ Investments & Acquisitions (4)
Deutsche Biotech Innovativ’s most recent deal was a Early Stage VC with Amidation Company for . The deal was made on 24-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Amidation Company | 24-Jan-2022 | Early Stage VC | Drug Discovery | ||
| Belano Medical | 31-Aug-2020 | Later Stage VC | Drug Discovery | ||
| Adrenomed | 17-Jun-2020 | Later Stage VC | Drug Discovery | ||
| AngioBiomed | 01-Feb-2015 | Merger/Acquisition | Drug Discovery |
Deutsche Biotech Innovativ ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Deutsche Biotech Innovativ Exits (3)
Deutsche Biotech Innovativ’s most recent exit was on 24-Jan-2022 from Amidation Company. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Amidation Company | 24-Jan-2022 | Completed |
|
||
| Belano Medical | 31-Aug-2020 | Completed |
|
||
| AngioBiomed | 01-Feb-2015 | Merger/Acquisition | Completed |
Deutsche Biotech Innovativ FAQs
-
When was Deutsche Biotech Innovativ founded?
Deutsche Biotech Innovativ was founded in 2009.
-
Where is Deutsche Biotech Innovativ headquartered?
Deutsche Biotech Innovativ is headquartered in Hennigsdorf, Germany.
-
What is the size of Deutsche Biotech Innovativ?
Deutsche Biotech Innovativ has 1 total employees.
-
What industry is Deutsche Biotech Innovativ in?
Deutsche Biotech Innovativ’s primary industry is Holding Companies.
-
Is Deutsche Biotech Innovativ a private or public company?
Deutsche Biotech Innovativ is a Public company.
-
What is Deutsche Biotech Innovativ’s stock symbol?
The ticker symbol for Deutsche Biotech Innovativ is DBI.
-
What is the current stock price of Deutsche Biotech Innovativ?
As of 30-Sep-2024 the stock price of Deutsche Biotech Innovativ is $1.24.
-
What is the current market cap of Deutsche Biotech Innovativ?
The current market capitalization of Deutsche Biotech Innovativ is $1.48M.
-
What is Deutsche Biotech Innovativ’s annual earnings per share (EPS)?
Deutsche Biotech Innovativ’s EPS for 12 months was -$1.26.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process